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Abstrak 
Latar belakang: Indonesia memiliki beberapa ramuan tradisional yang telah digunakan untuk mengurangi 
nyeri pada osteoarthritis (OA). Namun belum ada bukti yang kuat mengenai khasiat dan keamanan dari ramuan 
tradisional. Penelitian ini memberikan bukti mengenai khasiat dan keamanan dari satu ramuan tradisional. 
Metode: Penelitian ini menggunakan metode randomized clinical trial (RCT) dengan 123 subyek (pasien) 
selama 28 hari intervensi. Penelitian ini dilakukan pada bulan Maret – Desember 2014 oleh 30 dokter 
Saintifikasi Jamu di 20 provinsi. Formula jamu dibandingkan dengan piroksikam sebagai kontrol positif. 
Parameter yang digunakan untuk mengevaluasi khasiat formula jamu dan piroxicam adalah visual analogue 
score (VAS), pilot geriatric arthritis project (PGAP) functional status assessment (FSA), dan Short Form (SF)-
36. Untuk mengevaluasi keamanan digunakan nilai serum glutamic-oxaloacetic transaminase (SGOT), serum 
glutamic pyruvic transaminase level (SGPT), blood urea nitrogen (BUN), dan kreatinin. 
Hasil: Sebanyak 123 pasien yang dibagi menjadi dua kelompok yaitu 63 subyek pada kelompok formula 
jamu dan 60 subyek pada kelompok piroksikam. Pemberian jamu dapat menurunkan VAS secara bermakna 
(p<0,05) jika dibandingkan dengan hari ke-0. Nilai FSA kelompok jamu turun secara bermakna (p=0,000) jika 
dibandingkan dengan nilai di awal intervensi. Formula jamu dapat memperbaiki nilai SF-36 bila dibandingkan 
dengan hari ke-0. Nilai ketiga parameter antara jamu formula dan piroksikam, jika dibandingkan tidak 
berbeda bermakna (p>0,05). Kelompok formula jamu menunjukkan nilai SGOT, SGPT, BUN, dan kreatinin 
dalam ambang normal.
Kesimpulan: Penelitian ini menunjukkan bahwa ramuan jamu secara klinis, khasiatnya sebanding dengan 
piroxicam dan aman setelah intervensi selama 28 hari. (Health Science Journal of Indonesia 2016;7(2):84-92)
Kata kunci: khasiat, keamanan, RCT, ramuan
Abstract
Background: Indonesian herbs have several formulas which have been used traditionally to reduce pain of 
osteoarthritis (OA). However, there is a lack of evidence of its efficacy and safety. The objectives of study were 
to investigate the efficacy and safety of  a traditional formula for OA. 
Methods: Design of the study was a randomized clinical trial (RCT) involved 123 patients (subjects) for 28 days 
intervention. This study was conducted between March - December 2014 with 30 physicians were participated at 
20 regencies in Indonesia. The variables measured were VAS score, PGAP functional status assessment (FSA), 
and Short Form (SF-36) to assess jamu efficacy in comparison to piroxicam. To evaluate the safety of jamu 
formula using values of SGOT, SGPT, BUN, and creatinine. 
Result: The jamu formula administration effects can reduce VAS significantly  (p<0.05)  if it was compared 
to baseline. FSA score of jamu formula group was decreased significantly (p=0.000) when compared to the 
start of intervention. Short Form (SF)-36 of jamu formula group were significantly improved when compared 
with baseline value. The result of the three parameters between jamu group and piroxicam group should not 
significantly different. There was no difference in those parameters between both groups (p>0.05). In biological 
parameters, SGPT, SGOT, BUN, and creatinine level, showed normal range in both groups.
Conclusion: This study showed that the efficacy and safety of jamu formula was clinically comparable to 
piroxicam after 28 days of treatment. (Health Science Journal of Indonesia 2016;7(2):84-92)
Keywords: efficacy, safety, RCT, jamu formula
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Steoarthritis (OA) results from an imbalance between 
breakdown, repair of the tissues in the synovial joint 
organ and occurs as a result of multiple risk factors 
including trauma, overuse, and genetic predisposition. It 
was estimated that 9.9 million adults had symptomatic 
osteoarthritis of the knee in 2010. Risk factors of the 
condition increase with age, especially in women. 
Genetics, large body mass, certain occupations, 
repetitive knee bending or heavy lifting, and hereditary 
vulnerability are other factors that increase one’s risk 
of developing the disease.1
Some alternative therapy can be used to reduce OA. 
Neuromuscular electrical stimulation (NMES) is 
presented as a technique used by physical therapists,2 
and moderate pressure massage therapy can reduce 
pain and increase motion.3 Yoga and tai chi showed 
significant reductions in pain caused by OA[4]. 
Hundreds of herbal remedies are used for treating 
OA and the research literature, it reflect only a small 
percentage of them. It seems that herbal remedies 
could effective to lower or stop the consumption of 
Nonstreroidal Antiinlammatory Drugs (NSAIDs) 
and to reduce the incidence of adverse effect of 
NSAIDs.5
Randomized controlled trial (RCT) of traditional 
herbal formulation administrated by topical 
from chamomile oil, can decrease pain and 
consumption of analgesic.6 A lot of studies about 
oral herbal administrated are increasing and also 
interesting because it is compare with NSAIDs such 
as Chinese herbal recipes versus diclofenac. It shows 
that herbal recipes are as effective than conventional 
drug to reduce OA.7 Previous study of jamu formula 
has been done before with pre post design and it 
shows jamu formula can decrease the joint pain.8 
Indonesia has several herbs formulas which have been 
used traditionally to reduce pain of OA. The present 
study was conducted to investigate the efficacy and 
safety of traditional herbs formula that consist of 
Curcuma xanthorrhiza rhizome, Centella asiatica 
herbs, Curcuma domestica rhizome, Foeniculum 
vulgare seeds, Orthosiphon stamineus leaves, 
Phyllantus niruri herbs, Equisetum debile herbs. The 
efficacy of formula would be compared to piroxicam. 
The safety of formula would investigated by examined 
the kidney and heart function through evaluate the 
values of SGOT, SGPT, BUN, and creatinine.
METHODS 
Plants and piroxicam materials
The formula were prepared by Post Harvest Section, 
Department of  Research and Development Medicinal 
Plant and Traditional Medicine Center (B2P2TOOT) 
Tawangmangu Indonesia. The jamu was consisted of 
15g Curcuma xanthorrhiza dried rhizome, 3g Centella 
asiatica  dried herbs, 15g Curcuma domestica dried 
rhizome, 3g Foeniculum vulgare seeds, 5g Orthosiphon 
stamineus dried leaves, 7g Phyllantus niruri dried herbs, 
and 5g Equisetum debile dried herbs respectively.
Ten mg capsule of commercially marketed generic 
piroxicam were provided by PT. Indofarma (Indonesia). 
Subjects were selected randomly which use piroxicam, 
are presribed once daily 1 capsule, after meal.
Inclusion and exclusion criteria
Inclusion criteria of subject for this study were as 
follow: age within 50 – 70 years old, Visual Analogue 
Scale (VAS) that classified as medium or light 
cathegory with VAS  70  <VAS > 30 score, no history 
of allergic to herbal drugs, and did not take any other 
medication (analgesic, NSAIDs, etc) at least 2 weeks 
before intervention (washed out period). Exclusion 
criteria of subject included having complication 
diseases (subject’s medical record), gastritic disorder, 
ulcus pepticus or ulcus duodenum, allergic of 
bitter herbs, hypersentitive of curcumin, and taking 
medication during the study.
Study design
This study was conducted at Medicinal Plant and 
Traditional Medicine Research and Development 
Center, Tawangmangu, Indonesia. The study 
designed was a prospective, randomize, open label, 
and multicenter to evaluate efficacy and safety of 
jamu formula that claims reduce pain of OA. The 
study was carried out between March - December 
2014. Ethical clearance was approved by The Ethic 
Commission of Health Research and Development 
Department, Health Ministry Republic of Indonesia 
(LB.02.02/5.2/KE.148/2014).
Among 30 physicians and 123 patients were 
participated in this study. The physicians were 
from 20 regencies in Indonesia, who involved in 
Saintifikasi Jamu (SJ) program held by Ministry of 
Health Republic of Indonesia (Fig. 1). Prior to receive 
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treatment , all patient were checked on VAS score, 
PGAP functional status assessment (FSA), Short 
Form (SF-36), SGOT, SGPT, BUN, and creatinine. 
Every subject who had inclusion criteria, received 
form of compliance, and they should signed the form 
after they taken the jamu formula or piroxicam as 
well as when they forgot to take it. 
Efficacy and safety measures
The efficacy of jamu formula was assessed as baseline, 
at days 7, 14, 21, 28. These assessments consist of VAS 
that evaluated pain, PGAP functional status assessment 
(FSA), and SF-36. The safety was performed by 
examined the values of SGOT, SGPT, BUN, and 
creatinine, to assess kidney and liver function at 
baseline, days 14, and 28.
Besides VAS, this study used PGAP functional status 
assessment (FSA) to demonstrates its reliability in the 
dimension of degree of dependence in performing 
basic activities of daily living. There are three 
dimensions of this measurement namely dependency, 
difficulty, and pain for 44 different activities of daily 
living (Table 1). Dependence score were assigned 
as follows: 0 = independent, 1 = uses mechanical 
assistance, 2 = uses human assistance, 3 = uses both 
mechanical and human assistance, and 4 = cannot 
perform the activity even with maximum assistance. 
Score for degree of difficulty and pain were assigned 
on a 4-point scale which range from 1 = no pain/
difficulty, 2 = mild pain/difficulty, 3 = moderate pain/
difficulty, and 4 = severe pain/difficulty respectively .
Figure 1. Flowchart of recruitment and enrollment process.
Figure 2. Comparison VAS score between formula and piroxicam group
Received formula (n=63) 
 
Completers  
(n = 60) 
Completers 
 (n = 63) 
Received piroxicam (n=60) 
Eligibility screening by physician (n=123) 
 
Eligibility for laboratory screening (n=123) 
 
Enrolled for allocation in the study (n=123) 
 
Table 1. PGAP Functional Status Assessment (FSA) Instrument Items
Mobility Personal Care Work
Driving/Other transportation Using a Telephon Empoument/Ocupation
Shoping Writing Using Stove/Oven/Refrigerator
Walking Inside Cutting Food Using sink/faucets
Walking Outside Drinking Reaching Cupboards (High/Low)
Stairs in/to Home Ability to wash all areas Lifting Pots/Pans
Other Stairs Turning Faucets Peeling/ Cutting
Curbs Care of Teeth Opening containers
Transferring to/from bed Shaving Doing Laundry
Transferring to/from chair Combing Hair Sweeping/ Mopping
Transferring to/from toilet Setting Hair Cleaning Bathroom
Transferring to/from bath Putting on and tying shoes Washing Windows
Putting on hose/pants Doing home repairs
Putting on shirt/blouse Doing Yardwork
Buttoning/ Zipping Making beds
Putting on sweater/coat Washing dishes
Figure 1.  Flowchart of recruitment and enrollment process
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Jamu formula 
All subjects were instructed to boil 1L of water, and 
put jamu formula into boiling water, wait 15 minutes 
and stop the boiling process.  Let the water cooling 
down, filtered and take it each a glass three times a 
day after breakfast, lunch, and dinner.  
Statistical analysis
Data were analyzed statistically using a software 
proggrame for statistical analysis version 18.0. 
Descriptive data were calculated and presented as 
table to assess demographic characteristic, VAS, 
FSA, SF-36, and level of SGOT, SGPT, BUN, and 
creatinine between two groups.
RESULTS 
A total of 123 subjects (patients)  were randomly 
selected and administrated by jamu formula and 
piroxicam (17 male and 46 female in formula group, 
19 male and 41 female in piroxicam group).  The 
majority of patients are women, it shows that women 
have higher prevalence of OA than man at age of 
50 years or more [9].  The result shows that jamu 
formula and piroxicam group were not significantly 
different (p>0.05) in demographic data e.g., sex, 
age, occupation, body mass index (BMI), and 
duration of OA (Table. 2 ).
Table 2. Comparison of formula and piroxicam groups in term of demographic
Characteristic Formula group(n)
Piroxicam group
(n)
Total
(n) P
Age
50 – 60 y.o
61 -70 y.o
17
46
25
35
42
81
0,237a
Sex
Men
Women
17
46
19
41
36
87
0.043a
Occupation
Retired
Military/Police/Officer
Employee
Enterpreneur
Labor/farmer/fisherman
Other jobs
19
9
6
16
4
7
23
11
5
11
5
5
42
20
11
27
9
12
0.579 a
BMT
Underweight
Normoweight
Overweight
Obes 1
Obes 2
2
10
14
32
7
2
12
15
25
4
4
22
29
57
11
0.493a
Duration of  OA 41.25 months 40.36 months 0.356b
(a) Chi-square test;   (b) paired t test Figure 1. Flowchart of recruitment and enrollment process.
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This study was demonstrated the efficacy of the 
formula based on improvement of clinical parameters 
that were showed by VAS score, PGAP functional 
status assessment (FSA), and SF-36. VAS score that 
evaluated pain and stiffness, was assessed on the end of 
days 7, 14, 21, and 28. They were significantly different 
(p=0,000) if it was compared to their own VAS score on 
base-line. VAS score were decrease in both groups every 
time they were measured. To assess significantly VAS 
score between formula group and piroxicam group, 
was used independent t-test at the similar period. Mean 
baseline of both groups were not statistically significant 
(p=0,952) and the effect of formula and piroxicam on 
the end of days 7, 14, 21, and 28, were not statistically 
significant either (p>0.05) (Table. 3)
FSA score were measured on the end of day 7, 
14, 21, and 28. The values of FSA were decreased 
gradually on formula and piroxicam group every 
measured. FSA score on the end of day 7, 14, 21, 
and 28, were significantly different (p<0,05)  if it 
was compared to their own FSA score at baseline. To 
assess significantly FSA score between two groups, 
was used independent t-test at the similar period. 
Mean baseline of both groups were not statistically 
significant between them (p= 0,982). The jamu 
formula and piroxicam administration effects on FSA 
score statistically were not different (p>0,05) on the 
end of day 7, 14, 21, and 28 (Table 4).
Table 3. Comparison VAS score between formula and piroxicam group
VAS score Formula group(Mean+SD)
Piroxicam group
(Mean+SD)
p value
Baseline 59.44 + 10,.9 59.33 + 9.67 0.952; NS
Day 7 52.06 + 9.98 52.58 + 10.4 0.778; NS
Day 14 48.57 + 13.24 50.17 + 12.34 0.491; NS
Day 21 41.90 + 15.46 43.00 + 14.53 0.686; NS
Day 28 36.75 + 19.40 37.50 + 17.55 0.821; NS
Note: Statistical analysis was carried out using independent “t” test , p value p<0.05 (significant), NS = not significant
Figure 3. Comparison FSA score between formula and piroxicam group
Table 1. PGAP Functional Status Assessment (FSA) Instrument Items
Mobility Personal Care Work
Driving/Other transportation Using a Telephon Empoument/Ocupation
Shoping Writing Using 
Stove/Oven/Refrigerator
Walking Inside Cutting Food Using sink/faucets
Walking Outside Drinking Reaching Cupboards 
(High/Low)
Stairs in/to Home Ability to wash all areas Lifting Pots/Pans
Other Stairs Turning Faucets Peeling/ Cutting
Curbs Care of Teeth Opening containers
Transferring to/from bed Shaving Doing Laundry
Transferring to/from chair Combing Hair Sweeping/ Mopping
Transferring to/from toilet Setting Hair Cleaning Bathroom
Transferring to/from bath Putting on and tying 
shoes
Washing Windows
Putting on hose/pants Doing home repairs
Putting on shirt/blouse Doing Yardwork
Buttoning/ Zipping Making beds
Putting on sweater/coat Washing dishes
Table 2. Comparison of formula and piroxicam groups in term of demographic
Characteristic Formula group
(n)
Piroxicam group
(n)
Total
(n)
P
Age
50 – 60 y.o
61 -70 y.o
17
46
25
35
42
81
0,237a
Sex
Table 4.Comparison FSA score between jamu formula and piroxicam group
FSA score Formula group(Mean+SD)
Piroxicam group
(Mean+SD)
p value
Baseline 9.82 + 1.57 9.35 + 1.53 0.982; NS
Day 7 8.62 + 1.91 8.25 + 6.9 0.892; NS
Day 14 8.38 + 1.83 7.77 + 1.67 0.461; NS
Day 21 7.14 + 1.76 6.83 + 1.68 0.911; NS
Day 28 5.72 + 1.40 5.51 + 1.22 0.780; NS
Figure 3.  Comparison FSA score between formula and piroxicam group
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The Short Form (SF)-36 is a generic measure which 
generated a profile of eight dimensions and for which 
there is some evidence for validity in OA patients [10]. 
Eight dimension of the SF-36 are physical functioning, 
social functioning, physical limitations, emotional 
limitation, pain, mental health, vitality, and general 
health perception. In this parameter, patients were 
measured only at baseline, day 14 and 28 (every two 
weeks) for generic and condition-specific outcomes. 
The statistical significantly of formula and piroxicam 
group in SF scores were assessed using paired T test, 
and it was significantly improved when compared to 
their baseline (Table 5). They were not statistically 
significant when compared between both of them on 
the similar period (p>0,05) except social functioning 
dimension on baseline (p=0,047) (Table 6).
To assess safety of the formula on liver and renal 
functions, the levels of the biological profiles were 
measured on baseline (pre-treatment) and day 28 (post-
treatment). In biological  parameters, SGPT, SGOT, 
BUN, and Creatinine level, showed normal range in 
both groups. There was no significant alteration in the 
levels of SGPT, SGOT, BUN, and Creatinine when 
compared with their own baseline (p>0.05) (Table 7). 
The statistical significantly of formula versus piroxicam 
group were assessed using independent T test, there 
was no significant differences (p>0,05) of the biological 
parameters when compared between them (Table 8).
DISCUSSION
A challenge osteoarthritis treatment is deciding which 
medications will provide the greatest symptom relief 
with lowest serious adverse effects[11]. Meanwhile, 
people who use of complementary and alternative 
medicine (CAM) belief that  using“natural” 
treatments are safer than conventional medical 
treatments[12]. This study indicates the excellent 
efficacy and safety of the jamu formula and 
these promising OA symptoms relief result when 
compared with piroxicam as standart drug. Pain of 
the OA patient was significantly reduced after one 
week of formula intervention and much better after 
the end of intervention (day 28).  The formula was 
found to be safe based on SGPT, SGOT, BUN, and 
creatinine level, showed in normal range.
Table 5. Comparison of SF-36 score on baseline, day 14, and day 28
Dimensions of SF-36 Formula group Piroxicam group
Baseline Day 14 Day 28 Baseline Day 14 Day 28
Physical  functioning 85.87+20.51 90.40+11.61* 91.90+11.62* 83.58+15.57 89.75+13.35* 91.04+12.55*
Social functioning 76.19+19.67 80.75+17.22* 83.73+17.33* 74.38+22.95 76.88+19.50* 81.88+18.62*
Role Limitations 
(physical) 74.60+39.01 88.89+23.67* 91.47+20.80* 74.58+37.53 91.04+24.26* 92.08+21.34*
Role Limitations 
(emotional) 82.01+35.83 93.65+21.67* 95.77+18.45* 84.44+32.16 92.22+23.26* 92.92+20.29*
Pain 66.19+23.40 76.63+20.59* 81.94+21.42* 63.83+20.64 72.88+18.80* 80.08+20.47*
Mental health 74.60+15.29 76.83+14.32* 79.87+14.37* 70.53+14.34 74.33+14.06* 74.93+16.55*
Vitality 71.47+18.20 75.95+15.13* 78.81+15.86* 71.33+15.15 75.42+13.06* 77.00+16.15*
General health 
perceptions 61.35+19.01 63.73+15.50* 72.93+12.69* 64.67+16.18 66.83+12.85* 71.67+12.71*
Note : Statistical analysis was carryout using paired t test, pvalue <0.05 (significant), (*) significant compared with their own baseline
Table 6.  p values of SF-36 score between formula and piroxicam on similar period
Dimensions of SF-36 p values
Baseline Day 14 Day 28
Physical  functioning 0.318 0.835 0.616
Social functioning 0.047(*) 0.141 0.375
Role limitations (physical) 0.646 0.459 0.831
Role limitations (emotional) 0.352 0.498 0.143
Pain 0.354 0.431 0.733
Mental health 0.228 0.461 0.323
Vitality 0.163 0.178 0.465
General health perceptions 0.279 0.574 0.314
Note: Statistical analysis was carried out using independent t test, p<0.05 (significant), (*)significant
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The primary compound of jamu formula is curcuma 
(Zingiberaceae), the most frequently used in Indonesian 
herbs formula. Zingiberaceae are generally safe for human 
consumption [13]. Curcumin is the major compound 
of Curcuma domesticae and Curcuma xanthorriza. 
Curcumin showed a significant improvement in morning 
stiffness, walking time and reduction in joint swelling 
[14].  Other compound of jamu formula is Centella 
asiatica, it contains flavonoid (quercetin, kaempherol, 
catechin, rutin, etc), triterpene (Asiatic acid, madecassic 
acid, asiaticoside, madecassoside), and essential oil 
(sesquoterpene,α-humule, trans β-farnesene, farnese, 
gemacrene-D, bicyclogermacrene, β-caryophelene, 
and p-cymol[15]. The bioactive compound of Centella 
asiatica showed antioxidant activity that could have 
potential in preventing or slowing the progress of 
inflammation [16] such as osteoarthritis. 
Previous study indicated that an aerial part of 
Orthosipon stamineus from Indonesia, showed 
potent inhibitory activity against the NO production 
in lipopolysaccharide (LPS)-activated macrophages-
like J774 cells [17]. Increased concentration of nitrate, 
indicating elevated NO production in synovial fluid 
and serum of the inflamed joints on rheumatoid 
arthritis, ankylosing spondylitis, and osteoarthritis[18]. 
Various nonselective NO synthase inhibitors were 
used, such as orthosiphols A, B, D, X, H, K, M, and N, 
7-O-deacetylorthosiphol B, 6- hydroxyorthosiphol B, 
3-O-deacetylorthosiphol I, 2-O- deacetylorthosiphol J, 
neoorthosiphols A and B, norstaminol A,   siphonols  A–E, 
staminols  A–D,   orthosiphonone C and D, 14-deoxo-
14-O-acetylorthosiphol Y, 2-O- deacetylorthosiphonone 
A,  and neoorthosiphonone A[19].
Lignans are the important compounds in the 
Phyllantus niruri which have anti-inflammatory 
actions. Lignans seem to be directly or indirectly 
associated with their potency to inhibit ET-1 and to a 
lesser extent, PAF-mediated inflammatory responses 
[20]. In other compound, stem of Equisetum debile 
contains flavonoid, sterol, saponin and tannin. They 
are responsible to anti-inflammatory activities. The 
anti-inflammatory actions of Equisetum debile, can 
act centrally (such as narcotics) and peripherally 
(such as NSAIDs) but the exact mechanism remain 
in question [21]. 
Mechanism of herbal medicine for OA have not been 
clearly revealed, but interactions with inflammation 
mediators and reduce cartilage degradation maybe a 
rational approach to using herbal medicine[5]. This study 
used piroxicam for standard drug, because it is cheaper 
than other NSAIDs such as diclofenac and meloxicam. 
It widely used for OA pain in Indonesia. Piroxicam was 
used by patient just once a day, it increases compliance 
of patients. In other group, Foeniculum vulgare can 
increase compliances of the patients because of the 
fragrant. The fragrant can cover the bitter taste of 
formula. Study result showed there was a decrease 
of SGPT, SGOT, BUN, and creatinine level in jamu 
formula group, it shows nephro-protective [22,23,24] and 
hepato-protective [24,25] activities. Although, piroxicam 
group was an increased biological parameters but it still 
showed in normal range.
The knowledge of Jamu is part of the public health 
sector within the Indonesian health system. Jamu or 
herbal medicine in Indonesia has a important role in 
achieving a better equity of primary health care. Jamu 
Table  7. Comparison of formula and piroxicam groups in term of biological parameters
Parameters Formula (Mean+SD) Piroxicam (Mean+SD)
Baseline Day 28 p value* Baseline Day 28 p value*
SGOT 20.40+4.74 19.38+3.44 0.335; NS 20.77+4.61 20.88+4.70 0.344; NS
SGPT 20.75+4.71 19.94+4.23 0.267; NS 20.69+4.16 20.95+2.11 0.267; NS
BUN 24.06+5.79 23.96+5.86 0.145; NS 24.59+8.09 24.62+7.41 0.767; NS
Creatinine 0.876+0.27 0.817+0.27 0.328; NS 0.847+0.26 0.949+0.70 0.114; NS
Note: Statistical analysis was carried out using independent “t” test , p value p<0.05 (significant), (*) = significant
Table 8. P value of formula versus piroxicam group in term of biological parameters
Parameter p value
SGOT SGPT BUN Creatinine
Baseline 0.828; NS 0.404; NS 0.145; NS 0.691; NS
Day 28 0.260; NS 0.460; NS 0.288; NS 0.204; NS
Note: Statistical analysis was carried out using independent t test, p<0.05 (significant), NS= not significant
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in the daily life of many Indonesians have been used 
mainly for self-medication. Traditional/herbal medicine 
has its own market, providing medication to some of the 
need of Indonesian people. Diversity, flexibility, easy 
accessibility, broad continuing acceptance, relative low 
cost, low levels of technological input, relative low 
side effects and growing economic importance are 
some of the positive features of Jamu.
In conclusion, the study found that osteoarthritis 
herb formula is effective and safe alternative for pain 
relief of OA and clinically comparable efficacy and 
safety to piroxicam after 28 days intervention.
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